AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.2660
0.00 (0.00%)
At close: Jul 14, 2026, 4:00 PM EDT
0.2665
+0.0005 (0.19%)
After-hours: Jul 14, 2026, 8:00 PM EDT
AIM ImmunoTech Market Cap
AIM ImmunoTech has a market cap or net worth of $5.87 million as of July 14, 2026. Its market cap has decreased by -13.63% in one year.
Market Cap
5.87M
Enterprise Value
4.57M
1-Year Change
-13.63%
Ranking
Category
Stock Price
$0.27
Market Cap Chart
Since July 12, 1996, AIM ImmunoTech's market cap has decreased from $40.85M to $5.87M, a decrease of -85.62%. That is a compound annual growth rate of -6.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 5.87M | 82.20% |
| Dec 31, 2025 | 3.22M | -74.47% |
| Dec 31, 2024 | 12.63M | -41.22% |
| Dec 29, 2023 | 21.49M | 43.27% |
| Dec 30, 2022 | 15.00M | -65.93% |
| Dec 31, 2021 | 44.02M | -39.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XTL Biopharmaceuticals | 6.54M |
| Acurx Pharmaceuticals | 6.45M |
| Aptorum Group | 6.37M |
| Addex Therapeutics | 6.36M |
| BioAtla | 6.34M |
| Curanex Pharmaceuticals | 6.32M |
| Pulmatrix | 6.28M |
| Xenetic Biosciences | 6.27M |